<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01989754</url>
  </required_header>
  <id_info>
    <org_study_id>CR102647</org_study_id>
    <secondary_id>2013-003050-25</secondary_id>
    <secondary_id>28431754DIA4003</secondary_id>
    <nct_id>NCT01989754</nct_id>
  </id_info>
  <brief_title>A Study of the Effects of Canagliflozin (JNJ-28431754) on Renal Endpoints in Adult Participants With Type 2 Diabetes Mellitus</brief_title>
  <acronym>CANVAS-R</acronym>
  <official_title>A Randomized, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Canagliflozin on Renal Endpoints in Adult Subjects With Type 2 Diabetes Mellitus</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Janssen Research &amp; Development, LLC</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>The George Institute for Global Health, Australia</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Janssen Research &amp; Development, LLC</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to assess the effect of canagliflozin compared to placebo on
      progression of albuminuria in participants with Type 2 Diabetes Mellitus receiving standard
      care but with inadequate glycemic control and at elevated risk of cardiovascular events.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The study will be conducted in adult participants with Type 2 Diabetes Mellitus (T2DM),
      receiving standard of care for hyperglycemia and cardiovascular (CV) risk factors, who have
      either a history of a prior CV event or 2 or more risk factors for a CV event. Participants
      will be randomly assigned in a 1:1 ratio to canagliflozin or matching placebo to be taken
      once daily. Canagliflozin will be provided at a dose of 100 mg/day through Week 13 and then
      increased at the discretion of the investigator to a dose of 300 mg/day, if the participant
      requires additional glycemic control and is tolerating the 100 mg dose.

      The study consists of a 2-week screening period and a double-blind treatment period lasting
      between 78 and 156 weeks; study completion is targeted for when the last subject randomized
      has approximately 78 weeks of follow-up or when 688 major adverse cardiovascular events are
      accumulated between CANVAS and CANVAS-R. A total of 5,700 participants are targeted to be
      recruited into the study. Participants can be either drug na√Øve to antihyperglycemic agents,
      using monotherapy, or using combination of antihyperglycemic therapy for the control of blood
      glucose levels.

      The completion target was reached in February 2017.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 16, 2014</start_date>
  <completion_date type="Actual">February 23, 2017</completion_date>
  <primary_completion_date type="Actual">February 23, 2017</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Progression of Albuminuria</measure>
    <time_frame>Up to 3 years</time_frame>
    <description>Progression defined as the development of micro-albuminuria (Urine Albumin Creatinine Ratio [UACR] 30 to 300 milligram per gram [mg/g]) or macroalbuminuria (Albumin/creatinine ratio [ACR] of greater than [&gt;] 300 mg/g) in a participant with baseline normoalbuminuria (ACR less than [&lt;] 30 mg/g) or the development of macro-albuminuria in a participant with baseline microalbuminuria with an ACR increase greater than or equal to (&gt;=) 30 percent from baseline. Participants with macroalbuminuria at baseline (ACR&gt;300 mg/g) were excluded from the analysis. Event rate was estimated based on the time to the first occurrence of the event.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Composite of Cardiovascular (CV) Death Events or Hospitalization for Heart Failure</measure>
    <time_frame>Approximately 3 years</time_frame>
    <description>Analyses were using adjudicated events, that is (i.e.) CV death events or hospitalization due to heart failure, and adjudication of these outcomes by the Endpoint Adjudication Committee (EAC) were done in a blinded fashion. Event rate was estimated based on the time to the first occurrence of the event.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cardiovascular (CV) Death</measure>
    <time_frame>Approximately 3 years</time_frame>
    <description>Analyses were using adjudicated events, i.e. CV death events, and adjudication of these outcomes by the Endpoint Adjudication Committee (EAC) were done in a blinded fashion. Event rate was estimated based on the time to the first occurrence of the event.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">5813</enrollment>
  <condition>Diabetes Mellitus, Type 2</condition>
  <condition>Albuminuria</condition>
  <arm_group>
    <arm_group_label>Canagliflozin (JNJ-28431754)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Each patient will receive canagliflozin (JNJ-28431754) 100 mg once daily during the first 13 weeks, then the dose may be increased to 300 mg once daily.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Each patient will receive placebo (inactive medication) once daily.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>One placebo capsule taken orally (by mouth) once daily for 156 weeks</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Canagliflozin, 100 mg</intervention_name>
    <description>One 100 mg capsule taken orally (by mouth) once daily</description>
    <arm_group_label>Canagliflozin (JNJ-28431754)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Canagliflozin, 300 mg</intervention_name>
    <description>One 300 mg capsule taken orally (by mouth) once daily</description>
    <arm_group_label>Canagliflozin (JNJ-28431754)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Must have a diagnosis of type 2 diabetes mellitus

          -  Must have inadequate diabetes control (as defined by glycosylated hemoglobin level
             &gt;=7.0% to &lt;=10.5% at screening)

          -  Greater than or equal to (&gt;=) 30 yrs old with history of cardiovascular (CV) event, or
             &gt;= 50 yrs old with high risk of CV events

          -  Must be either not on antihyperglycemic agents (AHA) therapy, or on AHA monotherapy,
             or combination AHA therapy with any approved agent for the control of blood glucose
             levels.

        Exclusion Criteria

          -  History of diabetic ketoacidosis, type 1 diabetes mellitus, pancreas or beta-cell
             transplantation, or diabetes secondary to pancreatitis or pancreatectomy

          -  History of one or more severe hypoglycemic episode within 6 months before screening

          -  History of hereditary glucose-galactose malabsorption or primary renal glucosuria

          -  Ongoing, inadequately controlled thyroid disorder

          -  Renal disease that required treatment with immunosuppressive therapy or a history of
             chronic dialysis or renal transplant

          -  Myocardial infarction, unstable angina, revascularization procedure, or
             cerebrovascular accident within 3 months before screening.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Janssen Research &amp; Development, LLC Clinical Trial</last_name>
    <role>Study Director</role>
    <affiliation>Janssen Research &amp; Development, LLC</affiliation>
  </overall_official>
  <location>
    <facility>
      <address>
        <city>Little Rock</city>
        <state>Arkansas</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Carmichael</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Concord</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Pismo Beach</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Roseville</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Thousand Oaks</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Denver</city>
        <state>Colorado</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Hollywood</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Jacksonville</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>New Port Richey</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Opa-locka</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Orlando</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Palm Harbor</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Tampa</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Meridian</city>
        <state>Idaho</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Valparaiso</city>
        <state>Indiana</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Topeka</city>
        <state>Kansas</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Louisville</city>
        <state>Kentucky</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Mandeville</city>
        <state>Louisiana</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Metairie</city>
        <state>Louisiana</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Elkridge</city>
        <state>Maryland</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Flint</city>
        <state>Michigan</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Picayune</city>
        <state>Mississippi</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Kansas City</city>
        <state>Missouri</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Saint Louis</city>
        <state>Missouri</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Washington</city>
        <state>Missouri</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Omaha</city>
        <state>Nebraska</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Las Vegas</city>
        <state>Nevada</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Cornelius</city>
        <state>North Carolina</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Hickory</city>
        <state>North Carolina</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Mooresville</city>
        <state>North Carolina</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Canal Fulton</city>
        <state>Ohio</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Franklin</city>
        <state>Ohio</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Mason</city>
        <state>Ohio</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Oklahoma City</city>
        <state>Oklahoma</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Beaver</city>
        <state>Pennsylvania</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Levittown</city>
        <state>Pennsylvania</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Norristown</city>
        <state>Pennsylvania</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Tipton</city>
        <state>Pennsylvania</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Greer</city>
        <state>South Carolina</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Jefferson City</city>
        <state>Tennessee</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Austin</city>
        <state>Texas</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Pearland</city>
        <state>Texas</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Bountiful</city>
        <state>Utah</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Draper</city>
        <state>Utah</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Salt Lake City</city>
        <state>Utah</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>West Jordan</city>
        <state>Utah</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>South Burlington</city>
        <state>Vermont</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Falls Church</city>
        <state>Virginia</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Norfolk</city>
        <state>Virginia</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Virginia Beach</city>
        <state>Virginia</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Spokane</city>
        <state>Washington</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Milwaukee</city>
        <state>Wisconsin</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Wauwatosa</city>
        <state>Wisconsin</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Buenos Aires</city>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Ciudad Autonoma De Buenos Aires</city>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Ciudad De Buenos Aires</city>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Cordoba</city>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Mar Del Plata</city>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Moron</city>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Rosario</city>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Zarate, Buenos Aires</city>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Box Hill</city>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Cairns</city>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Daw Park</city>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Freemantle</city>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Liverpool</city>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Melbourne</city>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Newcastle</city>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Sherwood</city>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Sydney</city>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Tasmania</city>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Woden</city>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Woolloongabba</city>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Bonheiden</city>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Brugge</city>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Edegem</city>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Gent</city>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>La Louvi√®re</city>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Leuven</city>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Liege</city>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Li√øge</city>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Merksem</city>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Ransart</city>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Roeselare</city>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Tessenderlo</city>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Belem</city>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Belo Horizonte</city>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Campinas</city>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Caxias Do Sul</city>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Curitiba</city>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Fortaleza</city>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Mogi Das Cruzes</city>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Passo Fundo</city>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Porto Alegre</city>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Rio De Janeiro</city>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Sao Paulo</city>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>S√£o Jos√© Do Rio Preto</city>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>S√£o Paulo</city>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Coquitlam</city>
        <state>British Columbia</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Winnipeg</city>
        <state>Manitoba</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Halifax</city>
        <state>Nova Scotia</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Guelph</city>
        <state>Ontario</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Mississauga</city>
        <state>Ontario</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Oshawa</city>
        <state>Ontario</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Sarnia</city>
        <state>Ontario</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Thornhill</city>
        <state>Ontario</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Laval</city>
        <state>Quebec</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>L√©vis</city>
        <state>Quebec</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Quebec City</city>
        <state>Quebec</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Saint Marc Des Carri√©res</city>
        <state>Quebec</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Sherbrooke</city>
        <state>Quebec</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Westmont</city>
        <state>Quebec</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Saskatoon</city>
        <state>Saskatchewan</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Baotou</city>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Beijing</city>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Hangzhou</city>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Jinan</city>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Shenyang</city>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Wuxi</city>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Beroun</city>
        <country>Czechia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Ostrava</city>
        <country>Czechia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Plzen</city>
        <country>Czechia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Praha 10</city>
        <country>Czechia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Praha 1</city>
        <country>Czechia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Praha 4</city>
        <country>Czechia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Praha 8</city>
        <country>Czechia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Znojmo</city>
        <country>Czechia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Amiens</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Bois Guillaume</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Bordeaux</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Dijon</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Grenoble</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>La Rochelle Cedex 1</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Le Creusot</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Narbonne Cedex</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Paris</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Poitiers</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Aschaffenburg</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>A√ülar</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Bad Oeynhausen</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Dortmund</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Dresden</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Freiburg</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Hannover</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Kassel</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Mainz</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Neuwied</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Saarbr√ºcken</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Villingen-Schwenningen</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Balatonfured</city>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Budapest</city>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Duna√∫jv√°ros</city>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Eger</city>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Kecskem√©t</city>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Nagykanizsa</city>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Pecs</city>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Szekesfehervar</city>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Sziksz√≥</city>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Szombathely</city>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Zalaegerszeg</city>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>*Osenza*</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Arenzano</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Bologna</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Catanzaro</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Chieri (Torino)</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Firenze</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Messina</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Milano</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Napoli</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Ravenna</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Roma N/A</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Roma</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Sesto San Giovanni (Milano)</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Verona</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Ansan</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Bucheon</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Busan</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Changwon</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Cheongju</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Daegu</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Gyeonggi-Do</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Iksan</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Incheon</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Jeonju</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Seongnam-Si</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Seoul</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Suwon</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Ulsan</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Wonju-Si</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Batu Caves</city>
        <country>Malaysia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Georgetown</city>
        <country>Malaysia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Ipoh</city>
        <country>Malaysia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Kelantan</city>
        <country>Malaysia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Kota Bharu</city>
        <country>Malaysia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Kuala Lumpur</city>
        <country>Malaysia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Kuching</city>
        <country>Malaysia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Aguascalientes</city>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Celaya</city>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Cuernavaca</city>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Culiacan</city>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Guadalajara</city>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Mexico</city>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Pachuca De Soto</city>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Queretaro</city>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>San Luis Potosi</city>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Tampico</city>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Almelo</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Almere</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Amersfoort</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Amsterdam</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Dordrecht</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Eindhoven</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Groningen</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Hardenberg</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Hoogeveen</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Hoogezand</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Kloosterhaar</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Leiden</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Meppel</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Poortvliet</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Rotterdam</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Utrecht</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Velp</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Waalwijk</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Wamel</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Zoetermeer</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Zwijndrecht</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Auckland</city>
        <country>New Zealand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Christchurch</city>
        <country>New Zealand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Newtown</city>
        <country>New Zealand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Palmerston North</city>
        <country>New Zealand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Rotorua</city>
        <country>New Zealand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Tauranga</city>
        <country>New Zealand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Wellington</city>
        <country>New Zealand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Bialystok</city>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Bydgoszcz</city>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Chrzanow</city>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Gdansk</city>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Grodzisk Mazowiecki</city>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Katowice</city>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Krakow</city>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Lublin</city>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Oswiecim</city>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Torun</city>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Tychy</city>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Warszawa</city>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Wroclaw</city>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Ponce Pr</city>
        <country>Puerto Rico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Trujillo Alto</city>
        <country>Puerto Rico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Arkhangelsk</city>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Barnaul</city>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Chelyabinsk</city>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Kemerovo</city>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Nizhny Novgorod</city>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Penza</city>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Rostov-On-Don</city>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Saint Petersburg</city>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Saint-Petersburg</city>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Samara</city>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Saratov</city>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Smolensk</city>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>St Petersburg</city>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>St-Petersburg</city>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Syktyvkar</city>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Tyumen</city>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Vsevolzhsk</city>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Yaroslavl</city>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>A Coruna</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Alcal√° De Henares</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Alicante</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Almeria</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Alzira</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Barcelona</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Ciudad Real</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Cordoba</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Ferrol</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Figueres</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Galdakao</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Madrid</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Malaga</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>M√≥stoles</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Palma De Mallorca</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Sabadell</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>San Sebastian De Los Reyes</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Sant Joan D'Alacant</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Santa Cruz De Tenerife</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Santiago De Compostela</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Segovia</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Sevilla N/A</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Sevilla</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Valencia</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Viladecans</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Bor√•s</city>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Goteborg</city>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Helsingborg</city>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Karlstad</city>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Link√∂ping</city>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Lund</city>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Malmo</city>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Stockholm</city>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Uddevalla</city>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Uppsala</city>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Vallingby</city>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>V√§stra Fr√∂lunda</city>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Kaohsiung County</city>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Taichung</city>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Tainan</city>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Taipei</city>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Tiachung</city>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Xindian</city>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Cherkasy</city>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Chernivtsy</city>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Dnipropetrovsk</city>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Ivan-Frankivsk</city>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Ivano-Frankovsk</city>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Kharkiv</city>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Kharkov</city>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Kiev</city>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Kyiv</city>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Lviv</city>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Odesa</city>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Odessa</city>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Poltava</city>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Sumy</city>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Ternopil</city>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Uzhgorod</city>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Vinnitsa</city>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Vinnytsya</city>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Zaporizhzhia</city>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Zaporizhzhya</city>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Addlestone</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Belfast</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Birmingham</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Blackburn</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Bristol</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Bury St Edmunds</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Chesterfield</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Derby</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Doncaster</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Ipswich</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Leicester</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Liverpool</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Manchester</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Salford</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Taunton</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Torquay</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Truro</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Wellingborough</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Welwyn Garden City</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Argentina</country>
    <country>Australia</country>
    <country>Belgium</country>
    <country>Brazil</country>
    <country>Canada</country>
    <country>China</country>
    <country>Czechia</country>
    <country>France</country>
    <country>Germany</country>
    <country>Hungary</country>
    <country>Italy</country>
    <country>Korea, Republic of</country>
    <country>Malaysia</country>
    <country>Mexico</country>
    <country>Netherlands</country>
    <country>New Zealand</country>
    <country>Poland</country>
    <country>Puerto Rico</country>
    <country>Russian Federation</country>
    <country>Spain</country>
    <country>Sweden</country>
    <country>Taiwan</country>
    <country>Ukraine</country>
    <country>United Kingdom</country>
    <country>United States</country>
  </location_countries>
  <removed_countries>
    <country>Czech Republic</country>
  </removed_countries>
  <verification_date>November 2018</verification_date>
  <study_first_submitted>October 17, 2013</study_first_submitted>
  <study_first_submitted_qc>November 20, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 21, 2013</study_first_posted>
  <results_first_submitted>November 19, 2018</results_first_submitted>
  <results_first_submitted_qc>November 19, 2018</results_first_submitted_qc>
  <results_first_posted type="Actual">December 11, 2018</results_first_posted>
  <disposition_first_submitted>February 20, 2018</disposition_first_submitted>
  <disposition_first_submitted_qc>February 20, 2018</disposition_first_submitted_qc>
  <disposition_first_posted type="Actual">February 22, 2018</disposition_first_posted>
  <last_update_submitted>November 19, 2018</last_update_submitted>
  <last_update_submitted_qc>November 19, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">December 11, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Albuminuria</keyword>
  <keyword>Canagliflozin</keyword>
  <keyword>Cardiovascular outcomes</keyword>
  <keyword>Type 2 Diabetes Mellitus</keyword>
  <keyword>T2DM</keyword>
  <keyword>JNJ-28431754</keyword>
  <keyword>Antihyperglycemic Agent</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Albuminuria</mesh_term>
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 2</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Canagliflozin</mesh_term>
  </intervention_browse>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>September 1, 2016</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/54/NCT01989754/Prot_000.pdf</document_url>
    </provided_document>
    <provided_document>
      <document_type>Statistical Analysis Plan</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>March 20, 2017</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/54/NCT01989754/SAP_001.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <pre_assignment_details>A total of 5,813 participants were randomized. However, 1 participant was randomized twice and only the first randomization was included in the Intent-to-treat (ITT) analysis set. Thus 2,905 and 2,907 participants were randomly assigned to the placebo and canagliflozin groups in the ITT analysis set, respectively.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Placebo (Placebo)</title>
          <description>Participants received one capsule of matching placebo orally once daily for the duration of the study or until early discontinuation from treatment.</description>
        </group>
        <group group_id="P2">
          <title>Canagliflozin (Experimental)</title>
          <description>Participants received canagliflozin (JNJ-28431754) 100 milligram (mg) once daily during the first 13 weeks, then the dose was increased to 300 mg once daily (if the participant required additional glycemic control, provided the 100-mg dose was well tolerated).</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="2905"/>
                <participants group_id="P2" count="2907"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>Treated</title>
              <participants_list>
                <participants group_id="P1" count="2903"/>
                <participants group_id="P2" count="2904"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="2866">Participants who died are included in this category.</participants>
                <participants group_id="P2" count="2872">Participants who died are included in this category.</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="39"/>
                <participants group_id="P2" count="35"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="10"/>
                <participants group_id="P2" count="14"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="28"/>
                <participants group_id="P2" count="20"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Closed Site</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Placebo (Placebo)</title>
          <description>Participants received one capsule of matching placebo orally once daily for the duration of the study or until early discontinuation from treatment.</description>
        </group>
        <group group_id="B2">
          <title>Canagliflozin (Experimental)</title>
          <description>Participants received canagliflozin (JNJ-28431754) 100 milligram (mg) once daily during the first 13 weeks, then the dose was increased to 300 mg once daily (if the participant required additional glycemic control, provided the 100-mg dose was well tolerated).</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="2905"/>
            <count group_id="B2" value="2907"/>
            <count group_id="B3" value="5812"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="64" spread="8.28"/>
                    <measurement group_id="B2" value="63.9" spread="8.42"/>
                    <measurement group_id="B3" value="64" spread="8.35"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1111"/>
                    <measurement group_id="B2" value="1053"/>
                    <measurement group_id="B3" value="2164"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1794"/>
                    <measurement group_id="B2" value="1854"/>
                    <measurement group_id="B3" value="3648"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Ethnicity (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="586"/>
                    <measurement group_id="B2" value="604"/>
                    <measurement group_id="B3" value="1190"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Not Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2303"/>
                    <measurement group_id="B2" value="2290"/>
                    <measurement group_id="B3" value="4593"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="16"/>
                    <measurement group_id="B2" value="13"/>
                    <measurement group_id="B3" value="29"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="19"/>
                    <measurement group_id="B2" value="14"/>
                    <measurement group_id="B3" value="33"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="245"/>
                    <measurement group_id="B2" value="244"/>
                    <measurement group_id="B3" value="489"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="09"/>
                    <measurement group_id="B2" value="08"/>
                    <measurement group_id="B3" value="17"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="125"/>
                    <measurement group_id="B2" value="106"/>
                    <measurement group_id="B3" value="231"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2372"/>
                    <measurement group_id="B2" value="2393"/>
                    <measurement group_id="B3" value="4765"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                    <measurement group_id="B2" value="09"/>
                    <measurement group_id="B3" value="19"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="125"/>
                    <measurement group_id="B2" value="133"/>
                    <measurement group_id="B3" value="258"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race/Ethnicity, Customized</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>Asian</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="245"/>
                    <measurement group_id="B2" value="244"/>
                    <measurement group_id="B3" value="489"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Black or African American</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="125"/>
                    <measurement group_id="B2" value="106"/>
                    <measurement group_id="B3" value="231"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hispanic or Latino</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="407"/>
                    <measurement group_id="B2" value="437"/>
                    <measurement group_id="B3" value="844"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Other</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="174"/>
                    <measurement group_id="B2" value="172"/>
                    <measurement group_id="B3" value="346"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>White Non-Hispanic</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1954"/>
                    <measurement group_id="B2" value="1948"/>
                    <measurement group_id="B3" value="3902"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>ARGENTINA</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="146"/>
                    <measurement group_id="B2" value="159"/>
                    <measurement group_id="B3" value="305"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>AUSTRALIA</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="58"/>
                    <measurement group_id="B2" value="51"/>
                    <measurement group_id="B3" value="109"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>BELGIUM</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="86"/>
                    <measurement group_id="B2" value="66"/>
                    <measurement group_id="B3" value="152"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>BRAZIL</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="277"/>
                    <measurement group_id="B2" value="272"/>
                    <measurement group_id="B3" value="549"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CANADA</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="136"/>
                    <measurement group_id="B2" value="146"/>
                    <measurement group_id="B3" value="282"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CHINA</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="46"/>
                    <measurement group_id="B2" value="46"/>
                    <measurement group_id="B3" value="92"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CZECH REPUBLIC</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="67"/>
                    <measurement group_id="B2" value="72"/>
                    <measurement group_id="B3" value="139"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>FRANCE</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="69"/>
                    <measurement group_id="B2" value="55"/>
                    <measurement group_id="B3" value="124"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GERMANY</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="46"/>
                    <measurement group_id="B2" value="55"/>
                    <measurement group_id="B3" value="101"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>HUNGARY</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="82"/>
                    <measurement group_id="B2" value="97"/>
                    <measurement group_id="B3" value="179"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>ITALY</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="49"/>
                    <measurement group_id="B2" value="49"/>
                    <measurement group_id="B3" value="98"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>MALAYSIA</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="50"/>
                    <measurement group_id="B2" value="42"/>
                    <measurement group_id="B3" value="92"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>MEXICO</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="118"/>
                    <measurement group_id="B2" value="110"/>
                    <measurement group_id="B3" value="228"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>NETHERLANDS</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="117"/>
                    <measurement group_id="B2" value="132"/>
                    <measurement group_id="B3" value="249"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>NEW ZEALAND</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="49"/>
                    <measurement group_id="B2" value="56"/>
                    <measurement group_id="B3" value="105"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>POLAND</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="186"/>
                    <measurement group_id="B2" value="177"/>
                    <measurement group_id="B3" value="363"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>RUSSIAN FEDERATION</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="213"/>
                    <measurement group_id="B2" value="199"/>
                    <measurement group_id="B3" value="412"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>SOUTH KOREA</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="73"/>
                    <measurement group_id="B2" value="94"/>
                    <measurement group_id="B3" value="167"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>SPAIN</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="247"/>
                    <measurement group_id="B2" value="249"/>
                    <measurement group_id="B3" value="496"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>SWEDEN</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="118"/>
                    <measurement group_id="B2" value="103"/>
                    <measurement group_id="B3" value="221"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>TAIWAN</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="44"/>
                    <measurement group_id="B2" value="32"/>
                    <measurement group_id="B3" value="76"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>UKRAINE</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="213"/>
                    <measurement group_id="B2" value="236"/>
                    <measurement group_id="B3" value="449"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>UNITED KINGDOM</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="78"/>
                    <measurement group_id="B2" value="73"/>
                    <measurement group_id="B3" value="151"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>UNITED STATES</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="337"/>
                    <measurement group_id="B2" value="336"/>
                    <measurement group_id="B3" value="673"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Progression of Albuminuria</title>
        <description>Progression defined as the development of micro-albuminuria (Urine Albumin Creatinine Ratio [UACR] 30 to 300 milligram per gram [mg/g]) or macroalbuminuria (Albumin/creatinine ratio [ACR] of greater than [&gt;] 300 mg/g) in a participant with baseline normoalbuminuria (ACR less than [&lt;] 30 mg/g) or the development of macro-albuminuria in a participant with baseline microalbuminuria with an ACR increase greater than or equal to (&gt;=) 30 percent from baseline. Participants with macroalbuminuria at baseline (ACR&gt;300 mg/g) were excluded from the analysis. Event rate was estimated based on the time to the first occurrence of the event.</description>
        <time_frame>Up to 3 years</time_frame>
        <population>The intent to treat (ITT) population included all participants who were randomized. Here 'N' signifies number of participants who were evaluable for this endpoint.</population>
        <group_list>
          <group group_id="O1">
            <title>Placebo</title>
            <description>Participants received one capsule of matching placebo orally once daily for the duration of the study or until early discontinuation from treatment.</description>
          </group>
          <group group_id="O2">
            <title>Canagliflozin (Experimental)</title>
            <description>Participants received canagliflozin (JNJ-28431754) 100 milligram (mg) once daily during the first 13 weeks, then the dose was increased to 300 mg once daily (if the participant required additional glycemic control, provided the 100-mg dose was well tolerated).</description>
          </group>
        </group_list>
        <measure>
          <title>Progression of Albuminuria</title>
          <description>Progression defined as the development of micro-albuminuria (Urine Albumin Creatinine Ratio [UACR] 30 to 300 milligram per gram [mg/g]) or macroalbuminuria (Albumin/creatinine ratio [ACR] of greater than [&gt;] 300 mg/g) in a participant with baseline normoalbuminuria (ACR less than [&lt;] 30 mg/g) or the development of macro-albuminuria in a participant with baseline microalbuminuria with an ACR increase greater than or equal to (&gt;=) 30 percent from baseline. Participants with macroalbuminuria at baseline (ACR&gt;300 mg/g) were excluded from the analysis. Event rate was estimated based on the time to the first occurrence of the event.</description>
          <population>The intent to treat (ITT) population included all participants who were randomized. Here 'N' signifies number of participants who were evaluable for this endpoint.</population>
          <units>Events per 1000 patient-year</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="2905"/>
                <count group_id="O2" value="2907"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="153.01"/>
                    <measurement group_id="O2" value="99.80"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>&lt;.0001</p_value>
            <method>Cox proportional hazard method</method>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>0.64</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.57</ci_lower_limit>
            <ci_upper_limit>0.73</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Composite of Cardiovascular (CV) Death Events or Hospitalization for Heart Failure</title>
        <description>Analyses were using adjudicated events, that is (i.e.) CV death events or hospitalization due to heart failure, and adjudication of these outcomes by the Endpoint Adjudication Committee (EAC) were done in a blinded fashion. Event rate was estimated based on the time to the first occurrence of the event.</description>
        <time_frame>Approximately 3 years</time_frame>
        <population>ITT population included all participants who were randomized.</population>
        <group_list>
          <group group_id="O1">
            <title>Placebo</title>
            <description>Participants received one capsule of matching placebo orally once daily for the duration of the study or until early discontinuation from treatment.</description>
          </group>
          <group group_id="O2">
            <title>Canagliflozin (Experimental)</title>
            <description>Participants received canagliflozin (JNJ-28431754) 100 milligram (mg) once daily during the first 13 weeks, then the dose was increased to 300 mg once daily (if the participant required additional glycemic control, provided the 100-mg dose was well tolerated).</description>
          </group>
        </group_list>
        <measure>
          <title>Composite of Cardiovascular (CV) Death Events or Hospitalization for Heart Failure</title>
          <description>Analyses were using adjudicated events, that is (i.e.) CV death events or hospitalization due to heart failure, and adjudication of these outcomes by the Endpoint Adjudication Committee (EAC) were done in a blinded fashion. Event rate was estimated based on the time to the first occurrence of the event.</description>
          <population>ITT population included all participants who were randomized.</population>
          <units>Events per 1000 patient-years</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="2905"/>
                <count group_id="O2" value="2907"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="21.91"/>
                    <measurement group_id="O2" value="15.85"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>=0.0148</p_value>
            <method>Stratified Cox proportional hazard</method>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>0.72</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.55</ci_lower_limit>
            <ci_upper_limit>0.94</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Cardiovascular (CV) Death</title>
        <description>Analyses were using adjudicated events, i.e. CV death events, and adjudication of these outcomes by the Endpoint Adjudication Committee (EAC) were done in a blinded fashion. Event rate was estimated based on the time to the first occurrence of the event.</description>
        <time_frame>Approximately 3 years</time_frame>
        <population>ITT population included all participants who were randomized.</population>
        <group_list>
          <group group_id="O1">
            <title>Placebo</title>
            <description>Participants received one capsule of matching placebo orally once daily for the duration of the study or until early discontinuation from treatment.</description>
          </group>
          <group group_id="O2">
            <title>Canagliflozin (Experimental)</title>
            <description>Participants received canagliflozin (JNJ-28431754) 100 milligram (mg) once daily during the first 13 weeks, then the dose was increased to 300 mg once daily (if the participant required additional glycemic control, provided the 100-mg dose was well tolerated).</description>
          </group>
        </group_list>
        <measure>
          <title>Cardiovascular (CV) Death</title>
          <description>Analyses were using adjudicated events, i.e. CV death events, and adjudication of these outcomes by the Endpoint Adjudication Committee (EAC) were done in a blinded fashion. Event rate was estimated based on the time to the first occurrence of the event.</description>
          <population>ITT population included all participants who were randomized.</population>
          <units>Events per 1000 patient-years</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="2905"/>
                <count group_id="O2" value="2907"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11.60"/>
                    <measurement group_id="O2" value="10.06"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>=0.4067</p_value>
            <method>Stratified Cox proportional hazard</method>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>0.86</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.61</ci_lower_limit>
            <ci_upper_limit>1.22</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Approximately 3 years</time_frame>
      <desc>On-treatment analysis set included all randomized participants who were treated and received at least 1 dose of study drug. The number of deaths (all causes) reported here is adjudicated death that occurred within 30 days of the last dose of the study drug.</desc>
      <group_list>
        <group group_id="E1">
          <title>Placebo (Placebo)</title>
          <description>Participants received one capsule of matching placebo orally once daily for the duration of the study or until early discontinuation from treatment.</description>
        </group>
        <group group_id="E2">
          <title>Canagliflozin (Experimental)</title>
          <description>Participants received canagliflozin (JNJ-28431754) 100 milligram (mg) once daily during the first 13 weeks, then the dose was increased to 300 mg once daily (if the participant required additional glycemic control, provided the 100-mg dose was well tolerated).</description>
        </group>
      </group_list>
      <serious_events>
        <default_vocab>MedDRA Version 19.1</default_vocab>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="71" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="68" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="775" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="714" subjects_at_risk="2904"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>Anaemia</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="10" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Febrile Neutropenia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Iron Deficiency Anaemia</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Polycythaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Thrombocytopenia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2904"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Acute Coronary Syndrome</sub_title>
                <counts group_id="E1" subjects_affected="11" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Acute Left Ventricular Failure</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Acute Myocardial Infarction</sub_title>
                <counts group_id="E1" subjects_affected="26" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="32" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Adams-Stokes Syndrome</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Angina Pectoris</sub_title>
                <counts group_id="E1" subjects_affected="33" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="22" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Angina Unstable</sub_title>
                <counts group_id="E1" subjects_affected="42" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="42" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Aortic Valve Disease</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Aortic Valve Incompetence</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Arrhythmia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Arteriosclerosis Coronary Artery</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Atrial Fibrillation</sub_title>
                <counts group_id="E1" subjects_affected="18" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="14" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Atrial Flutter</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Atrial Tachycardia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Atrioventricular Block Complete</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Atrioventricular Block Second Degree</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Bradycardia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Cardiac Arrest</sub_title>
                <counts group_id="E1" subjects_affected="9" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Cardiac Disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Cardiac Failure</sub_title>
                <counts group_id="E1" subjects_affected="41" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="19" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Cardiac Failure Acute</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Cardiac Failure Chronic</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Cardiac Failure Congestive</sub_title>
                <counts group_id="E1" subjects_affected="18" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="11" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Cardiac Valve Disease</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Cardio-Respiratory Arrest</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Cardiogenic Shock</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Cardiopulmonary Failure</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Conduction Disorder</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Congestive Cardiomyopathy</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Coronary Artery Disease</sub_title>
                <counts group_id="E1" subjects_affected="29" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="34" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Coronary Artery Insufficiency</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Coronary Artery Occlusion</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Coronary Artery Stenosis</sub_title>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Diabetic Cardiomyopathy</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Ischaemic Cardiomyopathy</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Left Ventricular Dysfunction</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Left Ventricular Failure</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Mitral Valve Stenosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Myocardial Fibrosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Myocardial Infarction</sub_title>
                <counts group_id="E1" subjects_affected="24" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="31" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Myocardial Ischaemia</sub_title>
                <counts group_id="E1" subjects_affected="9" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Pericardial Effusion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Pericarditis</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Prinzmetal Angina</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Right Ventricular Failure</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Sinus Bradycardia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Sinus Node Dysfunction</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Supraventricular Tachycardia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Tachycardia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Tricuspid Valve Incompetence</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Ventricular Arrhythmia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Ventricular Asystole</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Ventricular Extrasystoles</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Ventricular Fibrillation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Ventricular Tachycardia</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Ear and labyrinth disorders</title>
            <event_list>
              <event>
                <sub_title>Haematotympanum</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Hypoacusis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Vertigo</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Endocrine disorders</title>
            <event_list>
              <event>
                <sub_title>Basedow's Disease</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Hyperparathyroidism</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Hyperparathyroidism Primary</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Hyperthyroidism</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2904"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Eye disorders</title>
            <event_list>
              <event>
                <sub_title>Amaurosis Fugax</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Cataract</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="10" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Diabetic Retinopathy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Diplopia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Eye Haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Eye Pain</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Eyelid Ptosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Glaucoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Macular Fibrosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Retinal Artery Occlusion</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Retinal Detachment</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Retinopathy</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2904"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Abdominal Hernia</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Abdominal Pain</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Abdominal Pain Lower</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Abdominal Pain Upper</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Anal Fistula</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Ascites</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Barrett's Oesophagus</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Bowel Movement Irregularity</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Colitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Colitis Ischaemic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Colitis Microscopic</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Colitis Ulcerative</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Colonic Pseudo-Obstruction</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Constipation</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Diarrhoea</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Diverticular Perforation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Diverticulum</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Diverticulum Intestinal</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Duodenal Ulcer</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Duodenal Ulcer Haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Duodenal Ulcer Perforation</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Enterocolitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Food Poisoning</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Gastric Polyps</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Gastroduodenitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Gastrointestinal Haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Haematemesis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Ileus</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Impaired Gastric Emptying</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Inguinal Hernia</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Intestinal Haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Intestinal Ischaemia</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Intestinal Obstruction</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Intestinal Ulcer Perforation</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Large Intestine Perforation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Lower Gastrointestinal Haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Melaena</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Mesenteric Arterial Occlusion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Mesenteric Vein Thrombosis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Oesophageal Obstruction</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Pancreatitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Pancreatitis Acute</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Peptic Ulcer</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Pneumoperitoneum</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Rectal Tenesmus</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Salivary Gland Calculus</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Salivary Gland Fistula</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Small Intestinal Obstruction</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Swollen Tongue</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Tooth Disorder</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Umbilical Hernia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Upper Gastrointestinal Haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Volvulus</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2904"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Adverse Drug Reaction</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Cardiac Death</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Chest Discomfort</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Chest Pain</sub_title>
                <counts group_id="E1" subjects_affected="17" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="22" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Complication Associated with Device</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Cyst</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Death</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Drug Intolerance</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Gait Disturbance</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Generalised Oedema</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Impaired Healing</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Malaise</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Non-Cardiac Chest Pain</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="9" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Oedema Peripheral</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Peripheral Swelling</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Pyrexia</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Sudden Cardiac Death</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Sudden Death</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Vascular Stent Restenosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Vascular Stent Thrombosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2904"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Hepatobiliary disorders</title>
            <event_list>
              <event>
                <sub_title>Bile Duct Stone</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Biliary Colic</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Cholangitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Cholangitis Acute</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Cholecystitis</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Cholecystitis Acute</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Cholelithiasis</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Cholelithiasis Obstructive</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Gallbladder Polyp</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Haemobilia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Hepatic Cirrhosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Hepatic Lesion</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Hydrocholecystis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Jaundice Cholestatic</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Liver Injury</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Non-Alcoholic Steatohepatitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2904"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Immune system disorders</title>
            <event_list>
              <event>
                <sub_title>Anaphylactic Reaction</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Drug Hypersensitivity</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Sarcoidosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Abscess</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Abscess Limb</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Abscess Neck</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Appendicitis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Arthritis Bacterial</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Bronchitis</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Campylobacter Gastroenteritis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Carbuncle</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Cellulitis</sub_title>
                <counts group_id="E1" subjects_affected="11" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="9" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Cellulitis Staphylococcal</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Cellulitis Streptococcal</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Cholecystitis Infective</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Colonic Abscess</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Device Related Infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Diabetic Foot Infection</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Diabetic Gangrene</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Diverticulitis</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Ear Infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Empyema</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Endocarditis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Epididymitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Erysipelas</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Escherichia Infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Escherichia Sepsis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Escherichia Urinary Tract Infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Eye Infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Gangrene</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Gastroenteritis</sub_title>
                <counts group_id="E1" subjects_affected="9" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="8" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Gastroenteritis Viral</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Genital Infection Fungal</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Hepatitis B</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Herpes Zoster</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Hiv Infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Infected Dermal Cyst</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Infected Skin Ulcer</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Infective Exacerbation of Chronic Obstructive Airways Disease</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Influenza</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Intervertebral Discitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Laryngitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Localised Infection</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Lower Respiratory Tract Infection</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Lung Abscess</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Mastoiditis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Orchitis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Osteomyelitis</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Osteomyelitis Chronic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Otitis Media Acute</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Parasitic Gastroenteritis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Paronychia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Pelvic Abscess</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Penile Abscess</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Perinephric Abscess</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Peritonsillar Abscess</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Pharyngotonsillitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Pneumococcal Sepsis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Pneumonia</sub_title>
                <counts group_id="E1" subjects_affected="31" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="26" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Pneumonia Legionella</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Pneumonia Pneumococcal</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Post Procedural Infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Post Procedural Sepsis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Postoperative Wound Infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Pulmonary Sepsis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Pulmonary Tuberculosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Pyelonephritis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Pyelonephritis Acute</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Respiratory Tract Infection</sub_title>
                <counts group_id="E1" subjects_affected="13" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Scrotal Abscess</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Scrotal Infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Sepsis</sub_title>
                <counts group_id="E1" subjects_affected="9" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Septic Shock</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Sinusitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Soft Tissue Infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Staphylococcal Infection</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Staphylococcal Sepsis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Stenotrophomonas Infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Subcutaneous Abscess</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Tooth Abscess</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Tooth Infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Tracheobronchitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Upper Respiratory Tract Infection</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Urinary Tract Infection</sub_title>
                <counts group_id="E1" subjects_affected="13" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="11" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Urinary Tract Infection Enterococcal</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Urosepsis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Wound Infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2904"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Ankle Fracture</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Arterial Bypass Stenosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Carotid Artery Restenosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Cataract Operation Complication</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Clavicle Fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Concussion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Contusion</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Craniocerebral Injury</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Epiphyseal Fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Eye Injury</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Facial Bones Fracture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Fall</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Femoral Neck Fracture</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Femur Fracture</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Fibula Fracture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Foot Fracture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Fractured Coccyx</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Hand Fracture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Head Injury</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Hip Fracture</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Humerus Fracture</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Jaw Fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Joint Dislocation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Laceration</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Ligament Sprain</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Limb Crushing Injury</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Limb Injury</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Lumbar Vertebral Fracture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Meniscus Injury</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Patella Fracture</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Pneumocephalus</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Post Laminectomy Syndrome</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Post Procedural Haematoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Post Procedural Haematuria</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Post Procedural Haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Postoperative Hernia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Postoperative Respiratory Failure</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Procedural Headache</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Procedural Pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Pubis Fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Radius Fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Rib Fracture</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Road Traffic Accident</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Spinal Fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Subarachnoid Haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Subdural Haematoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Suture Related Complication</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Tendon Injury</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Tendon Rupture</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Thermal Burn</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Thoracic Vertebral Fracture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Tibia Fracture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Toxicity to Various Agents</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Traumatic Fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Traumatic Ulcer</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Ulna Fracture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Upper Limb Fracture</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Vascular Graft Stenosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Wound</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Wound Dehiscence</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Wound Necrosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Wrist Fracture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2904"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Investigations</title>
            <event_list>
              <event>
                <sub_title>Arteriogram Coronary</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Blood Creatinine Increased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Blood Glucose Increased</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Ejection Fraction Decreased</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Electrocardiogram QT Prolonged</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Electrocardiogram St-T Change</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Electrocardiogram T Wave Inversion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>International Normalised Ratio Increased</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Liver Function Test Increased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Platelet Count Decreased</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>White Blood Cell Count Decreased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Metabolism and nutrition disorders</title>
            <event_list>
              <event>
                <sub_title>Acidosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Cachexia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Dehydration</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Diabetes Mellitus</sub_title>
                <counts group_id="E1" subjects_affected="18" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Diabetes Mellitus Inadequate Control</sub_title>
                <counts group_id="E1" subjects_affected="12" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Diabetic Complication</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Diabetic Ketoacidosis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Electrolyte Imbalance</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Fluid Overload</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Gout</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Hyperglycaemia</sub_title>
                <counts group_id="E1" subjects_affected="11" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Hyperkalaemia</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Hyperosmolar Hyperglycaemic State</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Hypertriglyceridaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Hypoglycaemia</sub_title>
                <counts group_id="E1" subjects_affected="9" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Hypokalaemia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Hyponatraemia</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Hypovolaemia</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Lactic Acidosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Metabolic Acidosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Obesity</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Type 2 Diabetes Mellitus</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Arthralgia</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Arthritis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Arthropathy</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Back Pain</sub_title>
                <counts group_id="E1" subjects_affected="11" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Bursitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Cervical Spinal Stenosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Costochondritis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Dactylitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Dupuytren's Contracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Extremity Contracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Foot Deformity</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Intervertebral Disc Compression</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Intervertebral Disc Disorder</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Intervertebral Disc Protrusion</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Knee Deformity</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Lumbar Spinal Stenosis</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Muscular Weakness</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Musculoskeletal Chest Pain</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Musculoskeletal Pain</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Osteitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Osteoarthritis</sub_title>
                <counts group_id="E1" subjects_affected="16" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="13" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Osteonecrosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Pathological Fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Plantar Fasciitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Polymyalgia Rheumatica</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Rhabdomyolysis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Rotator Cuff Syndrome</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Sacroiliitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Spinal Column Stenosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Spinal Osteoarthritis</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Spinal Pain</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Spondylolisthesis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Synovial Cyst</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Tendonitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Tenosynovitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Tenosynovitis Stenosans</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Trigger Finger</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Neoplasms benign, malignant and unspecified (incl cysts and polyps)</title>
            <event_list>
              <event>
                <sub_title>Acute Myeloid Leukaemia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Adenocarcinoma Gastric</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Adenocarcinoma of Colon</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Adenosquamous Cell Lung Cancer</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>B-Cell Lymphoma</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Basal Cell Carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Benign Lung Neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Benign Neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Benign Neoplasm of Thyroid Gland</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Bile Duct Cancer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Bladder Cancer</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Bladder Cancer Recurrent</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Bladder Transitional Cell Carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Bowen's Disease</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Breast Adenoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Breast Cancer</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Breast Cancer Metastatic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Breast Cancer Stage Ii</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Breast Cancer Stage Iii</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Cerebral Hygroma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Cholangiocarcinoma</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Chronic Myeloid Leukaemia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Colon Adenoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Colon Cancer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Colon Cancer Metastatic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Colorectal Adenocarcinoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Colorectal Cancer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Diffuse Large B-Cell Lymphoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Gastric Cancer</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Glioblastoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Hodgkin's Disease</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Invasive Ductal Breast Carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Large Cell Lung Cancer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Laryngeal Cancer</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Lipoma</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Lung Adenocarcinoma</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Lung Adenocarcinoma Metastatic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Lung Cancer Metastatic</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Lung Neoplasm Malignant</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Lymphoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Malignant Melanoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Malignant Melanoma in Situ</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Malignant Neoplasm of Unknown Primary Site</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Mediastinum Neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Meningioma Benign</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Metastases to Central Nervous System</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Metastases to Liver</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Neuroendocrine Carcinoma Metastatic</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Neuroendocrine Tumour</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Non-Hodgkin's Lymphoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Non-Small Cell Lung Cancer</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Oesophageal Squamous Cell Carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Ovarian Cancer Metastatic</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Pancreatic Carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Papillary Cystadenoma Lymphomatosum</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Papillary Thyroid Cancer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Plasma Cell Myeloma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Prostate Cancer</sub_title>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Prostate Cancer Metastatic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Rectal Cancer</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Renal Cancer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Schwannoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Serous Cystadenocarcinoma of Pancreas</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Small Cell Lung Cancer Metastatic</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Squamous Cell Carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Squamous Cell Carcinoma of Lung</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Squamous Cell Carcinoma of Skin</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Squamous Cell Carcinoma of the Oral Cavity</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Squamous Cell Carcinoma of the Tongue</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Tongue Neoplasm Malignant Stage Unspecified</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Ureteric Cancer</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Uterine Cancer</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Uterine Leiomyoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Basilar Artery Occlusion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Brain Injury</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Brain Stem Infarction</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Brain Stem Stroke</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Carotid Arteriosclerosis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Carotid Artery Occlusion</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Carotid Artery Stenosis</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="9" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Carpal Tunnel Syndrome</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Cerebellar Infarction</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Cerebral Haematoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Cerebral Haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Cerebral Infarction</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Cerebral Ischaemia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Cerebrovascular Accident</sub_title>
                <counts group_id="E1" subjects_affected="37" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="15" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Cervicobrachial Syndrome</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Cognitive Disorder</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Diabetic Mononeuropathy</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Diabetic Neuropathy</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Dizziness Postural</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Embolic Stroke</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Epilepsy</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Facial Nerve Disorder</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Generalised Tonic-Clonic Seizure</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Haemorrhagic Stroke</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Headache</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Hemiparesis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Hydrocephalus</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Hypertensive Encephalopathy</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Hypoxic-Ischaemic Encephalopathy</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Intraventricular Haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Ischaemic Cerebral Infarction</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Ischaemic Stroke</sub_title>
                <counts group_id="E1" subjects_affected="12" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="20" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Lacunar Infarction</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Lacunar Stroke</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Lethargy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Loss of Consciousness</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Lumbar Radiculopathy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Metabolic Encephalopathy</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Migraine</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Myasthenia Gravis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Myasthenia Gravis Crisis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Nerve Compression</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Neuralgia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Paraesthesia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Peripheral Nerve Paresis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Presyncope</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Radiculopathy</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Sciatica</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Seizure</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Sensory Loss</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Spinal Cord Compression</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Syncope</sub_title>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="10" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Thalamic Infarction</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Toxic Encephalopathy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Transient Ischaemic Attack</sub_title>
                <counts group_id="E1" subjects_affected="10" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="8" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Tremor</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Trigeminal Neuralgia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Vascular Encephalopathy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Vascular Headache</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Vertebral Artery Occlusion</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Vertebrobasilar Insufficiency</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Vocal Cord Paralysis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Product Issues</title>
            <event_list>
              <event>
                <sub_title>Device Breakage</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Device Loosening</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Device Malfunction</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Patient-Device Incompatibility</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Psychiatric disorders</title>
            <event_list>
              <event>
                <sub_title>Bipolar Disorder</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Completed Suicide</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Confusional State</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Delirium</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Depression</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Depression Suicidal</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Emotional Disorder</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Major Depression</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Psychotic Disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Suicidal Ideation</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Suicide Attempt</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>Acute Kidney Injury</sub_title>
                <counts group_id="E1" subjects_affected="15" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Bladder Obstruction</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Chronic Kidney Disease</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Diabetic Nephropathy</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Haematuria</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Hydronephrosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Ketonuria</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Nephrolithiasis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="8" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Nephropathy</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Nephropathy Toxic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Nephrotic Syndrome</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Pelvi-Ureteric Obstruction</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Pollakiuria</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Proteinuria</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Renal Colic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Renal Failure</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Renal Haematoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Renal Impairment</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Renal Injury</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Stress Urinary Incontinence</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Tubulointerstitial Nephritis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Ureterolithiasis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Urethral Stenosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Urinary Incontinence</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Urinary Retention</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Reproductive system and breast disorders</title>
            <event_list>
              <event>
                <sub_title>Balanoposthitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Benign Prostatic Hyperplasia</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Endometrial Hyperplasia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Endometrial Hypertrophy</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Epididymal Disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Erectile Dysfunction</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Fallopian Tube Cyst</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Metrorrhagia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Peyronie's Disease</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Prostatitis</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Prostatomegaly</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Uterine Polyp</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Uterine Prolapse</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Acute Pulmonary Oedema</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Acute Respiratory Distress Syndrome</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Acute Respiratory Failure</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Asthma</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Asthmatic Crisis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Atelectasis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Bronchitis Chronic</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Bronchospasm</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Chronic Obstructive Pulmonary Disease</sub_title>
                <counts group_id="E1" subjects_affected="11" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Cough</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Dyspnoea</sub_title>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="8" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Epistaxis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Haemoptysis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Haemothorax</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Hypoventilation</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Mediastinal Effusion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Nasal Obstruction</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Pleural Effusion</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Pneumonia Aspiration</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Pneumothorax</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Pulmonary Embolism</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Pulmonary Fibrosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Pulmonary Mass</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Pulmonary Oedema</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Pulmonary Sarcoidosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Respiratory Acidosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Respiratory Alkalosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Respiratory Failure</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Sleep Apnoea Syndrome</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Vocal Cord Leukoplakia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Angioedema</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Dermatitis Allergic</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Diabetic Foot</sub_title>
                <counts group_id="E1" subjects_affected="9" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="10" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Diabetic Ulcer</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Skin Fissures</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Skin Necrosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Skin Ulcer</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Urticaria</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2904"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Social circumstances</title>
            <event_list>
              <event>
                <sub_title>Penile Prosthesis User</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Victim of Homicide</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Surgical and medical procedures</title>
            <event_list>
              <event>
                <sub_title>Coronary Arterial Stent Insertion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Hospitalisation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Stent Placement</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Aortic Aneurysm</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Aortic Arteriosclerosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Aortic Stenosis</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Arterial Thrombosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Arteriosclerosis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Circulatory Collapse</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Deep Vein Thrombosis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Diabetic Vascular Disorder</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Extremity Necrosis</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Haematoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Hypertension</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Hypertensive Crisis</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Hypotension</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Hypovolaemic Shock</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Iliac Artery Occlusion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Intermittent Claudication</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Orthostatic Hypotension</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Peripheral Arterial Occlusive Disease</sub_title>
                <counts group_id="E1" subjects_affected="9" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="9" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Peripheral Artery Occlusion</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Peripheral Artery Stenosis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="8" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Peripheral Artery Thrombosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Peripheral Embolism</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Peripheral Ischaemia</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Peripheral Vascular Disorder</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="9" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Peripheral Venous Disease</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Poor Peripheral Circulation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Post Thrombotic Syndrome</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
              <event>
                <sub_title>Vascular Insufficiency</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2904"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>2</frequency_threshold>
        <default_vocab>MedDRA Version 19.1</default_vocab>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="25" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="94" subjects_at_risk="2904"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Reproductive system and breast disorders</title>
            <event_list>
              <event>
                <sub_title>Balanoposthitis</sub_title>
                <counts group_id="E1" subjects_affected="25" subjects_at_risk="2903"/>
                <counts group_id="E2" subjects_affected="94" subjects_at_risk="2904"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>If an investigator wishes to publish information from the study, a copy of the manuscript must be provided to the sponsor for review at least 60 days before submission for publication or presentation. If requested by the sponsor in writing, the investigator will withhold such publication for up to an additional 60 days.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Director Clinical Development</name_or_title>
      <organization>Janssen Research &amp; Development, LLC</organization>
      <phone>844-434-4210</phone>
      <email>ClinicalTrialDisclosure@its.jnj.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

